News for Solid Biosciences Inc. (SLDB)

**media[625381]**

Explore Solid Biosciences’ potential with promising SGT-003 trial results for DMD, strong financials, and market recovery opportunities. Learn more on SLDB stock here.

**media[587770]**

CHARLESTOWN, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company...

**media[582591]**

S&P 500 and Nasdaq had their worst quarters since 2022 due to concerns over Trump's economic policy and new tariffs. The S&P 500 dropped 4.6% and Nasdaq fell 10.5%. Tech stocks like Tesla and Nvidia saw major declines. Energy sector gained 9.3%. Goldman Sachs raised the recession probability to 35% amid ongoing uncertainty.

[url=

We recently published a list of Top 10 Insider Purchases Last Month. In this article, we are going to take a look at where Solid Biosciences Inc.

The average of price targets set by Wall Street analysts indicates a potential upside of 198.2% in Solid Biosciences (SLDB). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

**media[559669]**

CHARLESTOWN, Mass., March 05, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. ( SLDB) (the ”œCompany” or ”œSolid”), a life sciences company developing p

On February 18, 2025, COMMODORE CAPITAL LP (Trades, Portfolio) made a significant move by acquiring 5,825,000 shares of Solid Biosciences Inc (NASDAQ: SLDB) at

On February 19, 2025, Bain Capital Life Sciences Investors, LLC (Trades, Portfolio) made a significant move by acquiring an additional 1,000,000 shares in Solid

On February 19, 2025, Perceptive Advisors LLC made a significant move by acquiring an additional 5,028,033 shares of Solid Biosciences Inc (SLDB). This transact

On February 19, 2025, RA CAPITAL MANAGEMENT, L.P. (Trades, Portfolio) made a significant move by acquiring an additional 3,659,374 shares of Solid Biosciences I

The S&P 500 futures have risen by 22 points, trading 0.4% higher. Nasdaq 100 futures are up 93 points, also trading 0.4% higher. Dow Jones Industrial Average fu

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

CHARLESTOWN, Mass., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. ( SLDB) (the ”œCompany” or ”œSolid”), a life sciences company developing pr

Solid Biosciences Inc. (SLDB) Tuesday reported positive initial data from the Phase 1/2 INSPIRE DUCHENNE study of its gene therapy product candidate SGT-003 for the treatment of Duchenne muscular dystrophy.